The effectiveness of the parasternal intercostal nerve block for median sternotomy in cardiac surgery

The effectiveness of the parasternal intercostal nerve block for median sternotomy in cardiac surgery - The effectiveness of the intercostal nerve anterior cutaneous branch block

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000016077

Enrollment

Registered

2015-02-01

Start date

2015-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

median sternotomy in cardiac surgery

Interventions

parasternal intercostal nerve block with ropivacine 60ml(3mg/kg)(each10ml) [6 point of parasternal] parasternal intercostal nerve block with normal saline 60ml(each10ml) [6 point of parasternal]

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients scheduled valvular heart disease surgery Patients preoperative ADL is independent That obtained the written consent from the patient

Exclusion criteria

Exclusion criteria: Coronary artery bypass grafting Valvular disease surgery with coronary artery bypass grafting Not have the enough judgment ability Emergency surgery Hypersensitivity to ropivacaine or amide type local anesthetia Hemodialysis Renal dysfunction (less than eGFR30) Liver dysfunction patients (Child-Pugh classification more B)

Design outcomes

Primary

Measure	Time frame
Perioperative hemodynamics	—

Secondary

Measure	Time frame
Dose of opioids Time to extubation Length of intensive care unit Postoperative complications(Renal failure,P/F ratio,Pneumonia,Stroke,major bleeding,myocardial infraction) Postoperative 30days mortality Degree of postoperative pain(VAS)	—

Countries

Japan

Contacts

Public ContactTasuku Fujii

Nagoya University Hospital Department of Anesthesiology

plus9@med.nagoya-u.ac.jp052-744-2340

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026